IT1293088B1 - Microparticelle per il rilascio controllato di molecole biologicamente attive e loro uso in terapia, profilassi e diagnostica in vitro e in - Google Patents

Microparticelle per il rilascio controllato di molecole biologicamente attive e loro uso in terapia, profilassi e diagnostica in vitro e in

Info

Publication number
IT1293088B1
IT1293088B1 IT97RM000418A ITRM970418A IT1293088B1 IT 1293088 B1 IT1293088 B1 IT 1293088B1 IT 97RM000418 A IT97RM000418 A IT 97RM000418A IT RM970418 A ITRM970418 A IT RM970418A IT 1293088 B1 IT1293088 B1 IT 1293088B1
Authority
IT
Italy
Prior art keywords
microparticles
biologically active
active molecules
prophylaxis
diagnostics
Prior art date
Application number
IT97RM000418A
Other languages
English (en)
Inventor
Anders Carlsson
Elisabetta E Chiellini
Federica Chiellini
Jenny Cowdall
John Davies
Giuseppe Mazzanti
Mark Roberts
Erik Soderlind
Roberto Solaro
Original Assignee
Isi Ist Sierovaccinogeno Ital
Scotia Lipidteknik Ab
Polymer Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isi Ist Sierovaccinogeno Ital, Scotia Lipidteknik Ab, Polymer Lab Ltd filed Critical Isi Ist Sierovaccinogeno Ital
Priority to IT97RM000418A priority Critical patent/IT1293088B1/it
Publication of ITRM970418A0 publication Critical patent/ITRM970418A0/it
Priority to AT98932506T priority patent/ATE293958T1/de
Priority to ES98932506T priority patent/ES2242287T3/es
Priority to DE69829975T priority patent/DE69829975T2/de
Priority to PCT/IT1998/000192 priority patent/WO1999002135A1/en
Priority to EP98932506A priority patent/EP1003482B1/en
Priority to AU82409/98A priority patent/AU8240998A/en
Publication of ITRM970418A1 publication Critical patent/ITRM970418A1/it
Application granted granted Critical
Publication of IT1293088B1 publication Critical patent/IT1293088B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT97RM000418A 1997-07-10 1997-07-10 Microparticelle per il rilascio controllato di molecole biologicamente attive e loro uso in terapia, profilassi e diagnostica in vitro e in IT1293088B1 (it)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IT97RM000418A IT1293088B1 (it) 1997-07-10 1997-07-10 Microparticelle per il rilascio controllato di molecole biologicamente attive e loro uso in terapia, profilassi e diagnostica in vitro e in
AT98932506T ATE293958T1 (de) 1997-07-10 1998-07-09 Mikropartikel zur gesteuerten wirkstoffabgabe biologisch aktiver moleküle
ES98932506T ES2242287T3 (es) 1997-07-10 1998-07-09 Microparticulas para la administracion controlada de moleculas biologicamente activas.
DE69829975T DE69829975T2 (de) 1997-07-10 1998-07-09 Mikropartikel zur gesteuerten wirkstoffabgabe biologisch aktiver moleküle
PCT/IT1998/000192 WO1999002135A1 (en) 1997-07-10 1998-07-09 Microparticles for controlled delivery of biologically active molecules
EP98932506A EP1003482B1 (en) 1997-07-10 1998-07-09 Microparticles for controlled delivery of biologically active molecules
AU82409/98A AU8240998A (en) 1997-07-10 1998-07-09 Microparticles for controlled delivery of biologically active molecules

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97RM000418A IT1293088B1 (it) 1997-07-10 1997-07-10 Microparticelle per il rilascio controllato di molecole biologicamente attive e loro uso in terapia, profilassi e diagnostica in vitro e in

Publications (3)

Publication Number Publication Date
ITRM970418A0 ITRM970418A0 (it) 1997-07-10
ITRM970418A1 ITRM970418A1 (it) 1999-01-10
IT1293088B1 true IT1293088B1 (it) 1999-02-11

Family

ID=11405168

Family Applications (1)

Application Number Title Priority Date Filing Date
IT97RM000418A IT1293088B1 (it) 1997-07-10 1997-07-10 Microparticelle per il rilascio controllato di molecole biologicamente attive e loro uso in terapia, profilassi e diagnostica in vitro e in

Country Status (7)

Country Link
EP (1) EP1003482B1 (it)
AT (1) ATE293958T1 (it)
AU (1) AU8240998A (it)
DE (1) DE69829975T2 (it)
ES (1) ES2242287T3 (it)
IT (1) IT1293088B1 (it)
WO (1) WO1999002135A1 (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1407787T3 (da) 2001-06-20 2009-06-02 Dainippon Sumitomo Pharma Co Fremgangsmåde til fremme af nukleinsyreoverförsel
JP2008067717A (ja) * 2001-06-20 2008-03-27 Dainippon Sumitomo Pharma Co Ltd 核酸導入を促進させる方法
US7229966B2 (en) 2002-12-17 2007-06-12 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesity
US7186692B2 (en) 2002-12-17 2007-03-06 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery and non-infused administration of Y2 receptor-binding peptides and methods for treating and preventing obesity
EA008829B1 (ru) 2002-12-17 2007-08-31 Нэстек Фармасьютикал Кампани Инк. Композиции и способы для усовершенствованной доставки пептидов, связывающихся с y-рецепторами, которую осуществляют через слизистые оболочки, и способы лечения и предотвращения ожирения
US7166575B2 (en) 2002-12-17 2007-01-23 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity
WO2017077066A1 (en) 2015-11-06 2017-05-11 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Composition comprising a biocompatible and biodegradable polymer, nanocarries and a drug and methods of making and using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2660556B1 (fr) * 1990-04-06 1994-09-16 Rhone Poulenc Sante Microspheres, leur procede de preparation et leur utilisation.
IT1244511B (it) * 1991-04-15 1994-07-15 Isi Ist Sierovaccinogeno Ital Idrogeli a base di policarbossilati sintetici e proteine per il rilascio controllato di farmaci e procedimento per la loro preparazione.
DK0644771T4 (da) * 1992-06-11 2006-12-27 Alkermes Inc Lægemiddelsystem til levering af erythropoietin
AU6707194A (en) * 1993-04-19 1994-11-08 Medisorb Technologies International L.P. Encapsulation of nucleic acids with conjugates that facilitate and target cellular uptake and gene expression

Also Published As

Publication number Publication date
ATE293958T1 (de) 2005-05-15
WO1999002135A1 (en) 1999-01-21
DE69829975D1 (de) 2005-06-02
DE69829975T2 (de) 2006-03-09
ES2242287T3 (es) 2005-11-01
ITRM970418A0 (it) 1997-07-10
AU8240998A (en) 1999-02-08
EP1003482A1 (en) 2000-05-31
ITRM970418A1 (it) 1999-01-10
EP1003482B1 (en) 2005-04-27

Similar Documents

Publication Publication Date Title
DK1367944T3 (da) Plaster til skanning af et individs overfölsomhedstilstand for et allergen
ATE467430T1 (de) Endovaskuläres implantat mit einer zumindest abschnittsweisen aktiven beschichtung aus ratjadon und/oder einem ratjadon-derivat
SE9201128L (sv) Artificiellt fyllnings- och protesmaterial
BR0107942A (pt) Polìmeros de proteìna de liberação lenta
ATE339191T1 (de) Pulverpartikel mit glatter oberfläche zur verwendung in der inhalationstherapie
FI932320A (fi) Kontrollerbart frisaettande kompositioner
DE60022664D1 (de) Herstellungsverfahren von submikrometerwirkstoffpartikeln
EE04540B1 (et) Meetod bioloogiliselt sobivate biodegradeeruvate mikroosakeste valmistamiseks ja mikroosakeste kasutamine
MXPA04005127A (es) Composicion de tratamiento para el cabello comprendiendo particulas compuestas de arcilla y molecula organica cargada.
BR9305783A (pt) Processo para preparar grânulos dispersiveis em água e grânulos dispersíveis em água
DE59506057D1 (de) Kollagenzubereitung zur gesteuerten abgabe von wirkstoffen
ATE306254T1 (de) Zubereitungen mit verbesserter kontrollierter freisetzung
DE602004007802D1 (de) Subcutane implantate mit begrenzter initialer wirkstoff-freisetzung und deren anschliessende lineare veränderliche verlängerte freisetzung
IT1293088B1 (it) Microparticelle per il rilascio controllato di molecole biologicamente attive e loro uso in terapia, profilassi e diagnostica in vitro e in
ATE282474T1 (de) Infusionsdüse
MXPA04003596A (es) Dispositivo de liberacion de substancias.
ES2176459T3 (es) Patrones y soluciones de contraste estabilizados.
ES2194104T3 (es) Uso de selegilina para el tratamiento de la perdida de audicion en mamiferos.
ATE219781T1 (de) Verfahren zur herstellung superabsorbierender pulver mit hoher absorption und mit hoher kapillarer saugleistung
IT1261235B (it) Intonaco fine per interni e procedimento per la sua fabbricazione
DE60206056D1 (de) Herstellung von polymerteilchen
DE50013786D1 (de) Polyurethanharnstofffasern mit erhöhter festigkeit
WO2003003828A1 (fr) Materiau permettant d'ameliorer le cadre de vie, materiau de construction, materiau de pose et agent de projection utilisant ce materiau
JP2000279802A5 (it)
BR0010499A (pt) Agentes endoparasiticidas

Legal Events

Date Code Title Description
0001 Granted